SG Americas Securities LLC cut its stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT - Free Report) by 61.3% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 38,333 shares of the company's stock after se
Continue reading...
Continue reading...